1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc.

DWTX
Dogwood Therapeutics, Inc.US flagNASDAQ Capital Market
1.40
USD
+0.02
- -
2.68MMarket Cap

Income Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
2
2
10
16
12
5
12
28
+ Selling, General & Admin
1
1
10
5
4
4
9
6
+ Research & Development
1
1
- -
11
8
2
4
22
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-2
-2
-10
-16
-12
-5
-12
-28
- Non-Operating (Income) Loss
- -
- -
- -
- -
- -
- -
- -
6
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
- -
6
Pretax Income
-2
-2
-10
-16
-12
-5
-12
-34
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-2
-2
-10
-16
-12
-5
-12
-34
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-2
-2
-10
-16
-12
-5
-12
-34
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-2
-2
-10
-16
-12
-5
-12
-34
- Preferred Dividends
- -
- -
- -
- -
- -
- -
1
1
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-2
-2
-10
-16
-12
-5
-13
-36
EBIT
-2
-2
-10
-16
-12
-5
-12
-28
EBITDA
-2
-2
-10
-16
-12
-5
-12
-28
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
-2
-2
-10
-16
-12
-5
-12
-28
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
1
1
5
Basic EPS, GAAP
-10.93
-12.8
-52.5
-47.9
-27.66
-7.05
-12.52
-7.13
Basic EPS from Cont Ops
-10.93
-12.8
-52.5
-47.9
-27.66
-7.05
-12.02
-6.88
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
1
1
5
Diluted EPS, GAAP
-10.93
-12.8
-52.5
-47.9
-27.66
-7.05
-12.52
-7.13
Diluted EPS from Cont Ops
-10.93
-12.8
-52.5
-47.9
-27.66
-7.05
-12.02
-6.88

Balance Sheet (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
- -
- -
31
16
8
4
17
8
+ Cash, Cash Equivalents & STI
- -
- -
30
14
7
3
15
7
+ Cash & Cash Equivalents
- -
- -
30
14
7
3
15
7
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
2
2
1
1
2
2
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
- -
- -
78
82
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
78
82
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
78
81
+ Goodwill
- -
- -
- -
- -
- -
- -
12
12
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
66
69
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
- -
- -
31
16
8
4
94
90
+ Payables & Accruals
1
2
1
1
1
- -
2
2
+ Accounts Payable
- -
- -
- -
- -
1
- -
1
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
2
1
- -
- -
- -
1
1
+ ST Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
1
1
- -
- -
1
1
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
1
1
- -
- -
1
1
Total Current Liabilities
1
2
2
1
1
- -
3
3
+ LT Debt
- -
4
- -
- -
- -
- -
16
- -
+ LT Borrowings
- -
4
- -
- -
- -
- -
15
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
11
12
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
11
12
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
4
- -
- -
- -
- -
27
12
Total Liabilities
1
5
2
1
1
- -
30
15
+ Preferred Equity and Hybrid Capital
1
- -
- -
- -
- -
- -
74
- -
+ Share Capital & APIC
13
13
58
58
63
66
68
184
+ Common Stock
13
13
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
58
58
63
66
68
184
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-15
-18
-28
-44
-56
-61
-74
-108
+ Other Equity
- -
- -
- -
- -
- -
- -
-4
-1
Equity Before Minority Interest
-1
-5
30
15
7
4
64
75
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-1
-5
30
15
7
4
64
75
Total Liabilities & Equity
- -
- -
31
16
8
4
94
90
Shares Outstanding
- -
- -
- -
- -
1
1
1
30
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
- -
3
-30
-14
-7
-3
1
-7
Net Debt to Equity
2.38
-67.34
-99.51
-96.6
-95.97
-87.13
0.83
-8.71
Tangible Common Equity Ratio
-3,858.17
-1,588.32
95.13
91.91
87.54
91.39
-522.17
-73.87
Current Ratio
0.03
0.19
20.55
12.37
8.02
11.62
5.21
2.76
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-2
-2
-10
-16
-12
-5
-12
-34
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
- -
7
- -
1
1
4
19
+ Stock-Based Compensation
- -
- -
7
- -
1
1
- -
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
- -
- -
- -
4
18
+ Chg in Non-Cash Work Cap
1
- -
-1
- -
- -
- -
-1
- -
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-2
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
1
- -
1
- -
- -
-1
- -
- -
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-1
-2
-4
-16
-11
-5
-9
-16
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
31
- -
4
1
1
4
+ Increase in Capital Stock
- -
- -
31
- -
4
1
1
4
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
4
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
4
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
- -
4
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
2
2
- -
- -
- -
15
3
+ Cash From Debt
- -
2
2
- -
- -
- -
15
3
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
1
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
1
2
33
- -
4
1
17
7
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
- -
29
-16
-7
-4
12
-8
EBITDA
-2
-2
-10
-16
-12
-5
-12
-28
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-1
-2
-4
-16
-11
-5
-9
-16
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
-4
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-1
-2
-16
-11
-5
80
-88
Free Cash Flow per Basic Share
-6.19
-10.82
-19.76
-47.09
-25.9
-6.48
-8.55
-3.14
Price/Free Cash Flow
- -
- -
-9.5
-2.72
-0.23
-2.22
-0.29
-1.33
Cash Flow to Net Income
0.57
0.85
0.38
0.98
0.94
0.92
0.71
0.46
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -